Researchers have specified specific genetic markers that may predict which patients with obesity are most likely to respond strongly to Novo Nordisk’s weight-loss
Researchers have specified specific genetic markers that may predict which patients with obesity are most likely to respond strongly to Novo Nordisk’s weight-loss